Beyond Air Receives Grant for Up to $2.17 million from the Cystic Fibrosis Foundation to Advance the Clinical Development of Inhaled Nitric Oxide to Treat Nontuberculous Mycobacteria Pulmonary Disease

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    ENP Newswire. February 17, 2021